Dynamic Matching with Better-than-2 Approximation in Polylogarithmic Update Time

被引:0
|
作者
Bhattacharya, Sayan [1 ]
Kiss, Peter [2 ]
Urak, Thatchaphol saran [3 ]
Wajc, David [4 ]
机构
[1] Univ Warwick, Coventry, England
[2] Univ Warwick, Dept Comp Sci, Coventry, England
[3] Univ Michigan, Ann Arbor, MI USA
[4] Technion Israel Inst Technol, Haifa, Israel
基金
英国工程与自然科学研究理事会;
关键词
Dynamic algorithms; approximate matching; MINIMUM VERTEX COVER; MAXIMUM; ALGORITHMS;
D O I
10.1145/3679009
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
We present dynamic algorithms with polylogarithmic update time for estimating the size of the maximum matching of a graph undergoing edge insertions and deletions with approximation ratio strictly better than 2. Specifically, we obtain a 1+ root 21 + & varepsilon; approximate to 1.707+& varepsilon; approximation in bipartite graphs and a 1.973+& varepsilon; approximation in general graphs. We thus answer in the affirmative the value version of the major open question repeatedly asked in the dynamic graph algorithms literature. Our randomized algorithms' approximation and worst-case update time bounds both hold w.h.p. against adaptive adversaries. Our algorithms are based on simulating new two-pass streaming matching algorithms in the dynamic setting. Our key new idea is to invoke the recent sublinear-time matching algorithm of Behnezhad (FOCS'21) in a white-box manner to efficiently simulate the second pass of our streaming algorithms, while bypassing the well-known vertex-update barrier.
引用
收藏
页数:32
相关论文
共 47 条
  • [41] SC peginterferon beta-1a every 2 weeks demonstrated better clinical outcomes than SC interferon beta-1a TIW in patients with RMS, using a matching-adjusted comparison of 5 Phase 3 trials
    Coyle, Patricia
    Shang, Shulian
    Castrillo-Viguera, Carmen
    NEUROLOGY, 2017, 88
  • [42] SC peginterferon beta-1a every 2 weeks demonstrated better clinical outcomes than SC interferon beta-1a TIW in patients with RMS, using a matching-adjusted comparison of 7 Phase 3 trials
    Coyle, P.
    Shang, S.
    You, X.
    Castrillo-Viguera, C.
    Fiore, D.
    Werneburg, B.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 776 - 776
  • [43] Intraoperative Rectal D2cc Monitoring Reduces Rectal Doses More Than Using V100 Alone in Real Time Dynamic LDR Prostate Brachytherpy
    James, E.
    Doggart, A. J.
    Rogers, P. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S491 - S491
  • [44] Peginterferon beta-1a every 2 weeks demonstrated better outcomes than glatiramer acetate (GA) once daily in patients with relapsing-remitting multiple sclerosis (RRMS): propensity score matching (PSM) of phase 3 data from ADVANCE and CONFIRM
    Scott, Thomas
    Mokliatchouk, Oksana
    Castrillo-Viguera, Carmen
    Harrington, Adrian
    Naylor, Maria
    NEUROLOGY, 2019, 92 (15)
  • [45] Peginterferon beta-1a every 2 weeks demonstrates better clinical outcomes than glatiramer acetate 40 mg/mL 3 times a week in patients with relapsing-remitting multiple sclerosis using a matching-adjusted indirect comparison of phase 3 trials
    Scott, T.
    Su, R.
    Naylor, M. L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 864 - 865
  • [47] Would the one-stage combined approach lead to better long-term neurological outcomes than the posterior approach alone in multilevel degenerative cervical myelopathy patients with T2-Weighted increased signal intensity? An 8-year follow-up results and propensity score matching analysis
    Qu, Ruomu
    Wang, Ben
    Yang, Yiyuan
    Liu, Zexiang
    Chen, Zhuo
    Wu, Yunxia
    Li, Xiumao
    Jiang, Liang
    Liu, Xiaoguang
    Liu, Zhongjun
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)